XT
PDSB icon

XTX Topco’s PDS Biotechnology PDSB Stock Holding History

XTX Topco’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.2K Sell
33,098
-3,113
-9% -$3.3K ﹤0.01% 3832
2026
Q1 		$21.9K Buy
36,211
+1,993
+6% +$1.5K ﹤0.01% 3527
2025
Q4 		$26.3K Buy
34,218
+14,519
+74% +$13.1K ﹤0.01% 3000
2025
Q3 		$19.9K Buy
+19,699
New +$23.2K ﹤0.01% 2329
2025
Q1 		– Sell
-24,535
Closed -$40K – 2927
2024
Q4 		$40K Sell
24,535
-42,647
-63% -$113K ﹤0.01% 1936
2024
Q3 		$257K Buy
67,182
+47,528
+242% +$159K 0.02% 1294
2024
Q2 		$57.6K Sell
19,654
-40,600
-67% -$130K ﹤0.01% 1496
2024
Q1 		$239K Buy
+60,254
New +$310K 0.03% 1037
2022
Q3 		– Sell
-21,085
Closed -$77K – 1316
2022
Q2 		$77K Buy
+21,085
New +$100K 0.03% 698

Other funds holding PDSB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
MCM
Militia Capital Management Austin, Texas $3.37B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

XTX Topco's PDSB Position: Q2 2026 in Review

XTX Topco reduced its PDS Biotechnology (PDSB) stake by 8.6% in Q2 2026, selling an estimated $3.3K and leaving 33,098 shares worth $29.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3832.

XTX Topco first reported a position in PDSB in Q2 2022 and has held it in 9 quarters since. The position peaked at $257K in Q3 2024. 52 funds tracked by Wall St. Rank hold PDSB as of Q2 2026.

  • XTX Topco held 33,098 shares of PDS Biotechnology worth $29.2K as of Q2 2026.
  • XTX Topco sold 3,113 PDS Biotechnology shares in Q2 2026, an estimated $3.3K.
  • PDS Biotechnology made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3832 holding.
  • XTX Topco first reported a position in PDS Biotechnology in Q2 2022 and has held it in 9 quarters since.
  • XTX Topco's PDS Biotechnology position peaked at $257K in Q3 2024.
  • 52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.